Annovis Bio Inc ANVS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:54 PM EDT
8.72UNCH (UNCH)
Volume
6,574
Close
8.72quote price arrow up+0.36 (+4.31%)
Volume
999,003
52 week range
4.79 - 22.49
Loading...
  • Open8.50
  • Day High10.40
  • Day Low8.49
  • Prev Close8.36
  • 52 Week High22.49
  • 52 Week High Date12/27/23
  • 52 Week Low4.79
  • 52 Week Low Date05/08/24

Key Stats

  • Market Cap97.415M
  • Shares Out11.17M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-53.37

KEY STATS

  • Open8.50
  • Day High10.40
  • Day Low8.49
  • Prev Close8.36
  • 52 Week High22.49
  • 52 Week High Date12/27/23
  • 52 Week Low4.79
  • 52 Week Low Date05/08/24
  • Market Cap97.415M
  • Shares Out11.17M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-53.37

RATIOS/PROFITABILITY

  • EPS (TTM)-6.12
  • P/E (TTM)-1.42
  • Fwd P/E (NTM)-3.73
  • EBITDA (TTM)-45.035M
  • ROE (TTM)-546.40%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Annovis Bio Inc

 

Profile

MORE
Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced small molecule, orally administered, brain penetrant compound. Its product candidate...
Michael Hoffman
Independent Chairman of the Board
Maria Maccecchini Ph.D.
President, Chief Executive Officer, Founder, Interim Principal Financial Officer, Director
Address
101 LINDENWOOD DRIVE, SUITE 225
Malvern, PA
19355
United States

Top Peers

SYMBOLLASTCHG%CHG
LTRN
Lantern Pharma Inc
6.33+0.14+2.26%
LABP
Landos Biopharma Inc
22.35-0.10-0.45%
IFRX
InflaRx NV
1.40-0.03-2.10%
TSBX
Turnstone Biologics Corp
2.76-0.11-3.83%
TARA
Protara Therapeutics Inc
3.71+0.37+11.08%